KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Other financing activities (2017 - 2026)

Johnson & Johnson's Other financing activities history spans 13 years, with the latest figure at -$588.0 million for Q1 2026.

  • On a quarterly basis, Other financing activities fell 1570.0% to -$588.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$662.0 million, a 627.47% decrease, with the full-year FY2025 number at -$34.0 million, up 10.53% from a year prior.
  • Other financing activities hit -$588.0 million in Q1 2026 for Johnson & Johnson, down from -$26.0 million in the prior quarter.
  • Over the last five years, Other financing activities for JNJ hit a ceiling of $186.0 million in Q3 2023 and a floor of -$588.0 million in Q1 2026.
  • Historically, Other financing activities has averaged -$76.8 million across 5 years, with a median of -$37.5 million in 2025.
  • Biggest five-year swings in Other financing activities: crashed 4700.0% in 2023 and later soared 138.91% in 2024.
  • Tracing JNJ's Other financing activities over 5 years: stood at -$138.0 million in 2022, then plummeted by 178.26% to -$384.0 million in 2023, then soared by 80.47% to -$75.0 million in 2024, then soared by 65.33% to -$26.0 million in 2025, then tumbled by 2161.54% to -$588.0 million in 2026.
  • Business Quant data shows Other financing activities for JNJ at -$588.0 million in Q1 2026, -$26.0 million in Q4 2025, and -$49.0 million in Q3 2025.